SHAYLA SANDERS: Open Payments
NPI 1841607900 · CORYDON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$50,149 in 127 payments from 10 companies in 2025. Trend: 2023 $100,343 · 2024 $65,178 · 2025 $50,149
Speaker / faculty: $30,270Travel & lodging: $14,872Food & beverage: $2,626Consulting: $2,304Education: $77
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 68 | $41,514 |
| ABBVIE INC. | 23 | $2,664 |
| GlaxoSmithKline, LLC. | 13 | $2,192 |
| SOBI, INC | 5 | $1,677 |
| Novartis Pharmaceuticals Corporation | 5 | $1,339 |
| Janssen Biotech, Inc. | 4 | $256 |
| Mallinckrodt Hospital Products Inc. | 4 | $242 |
| GENZYME CORPORATION | 2 | $204 |
| ANI Pharmaceuticals, Inc. | 2 | $45 |
| UCB, Inc. | 1 | $18 |
Products named: KRYSTEXXA, RINVOQ, BENLYSTA, TREMFYA, ACTHAR, KEVZARA, SKYRIZI, EVENITY.
Industry payments across IA — which companies pay providers there.
